VX-105: Began Phase II trial

Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass. Product: VX-105 modulator of gene expression for fetal hemoglobin (hemoglobin F) Indication: Sickle cell anemia Status: Began Phase II trial in up ...